These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2514364)

  • 1. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.
    Battaglia G; De Souza EB
    NIDA Res Monogr; 1989; 94():240-58. PubMed ID: 2514364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.
    Ritz MC; Kuhar MJ
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1010-7. PubMed ID: 2703961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies.
    De Souza EB; Battaglia G
    NIDA Res Monogr; 1989; 94():196-222. PubMed ID: 2575225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple serotonin receptors and their physiological significance.
    Peroutka SJ; Snyder SH
    Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.
    Lyon RA; Glennon RA; Titeler M
    Psychopharmacology (Berl); 1986; 88(4):525-6. PubMed ID: 2871581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML; Colbert WE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
    Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
    Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of serotonin receptors.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
    Harhammer R; Schäfer U; Ott T
    Arzneimittelforschung; 1992 Oct; 42(10):1175-9. PubMed ID: 1472137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.